A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

Metabolic syndrome (MetS) in patients with schizophrenia occurs 2–3 times more frequently than in the general population. Antipsychotic medication is a primary risk factor for patients with MetS. In particular, the widely used second-generation antipsychotics can affect glucose and lipid metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xuemei, Ye, Hui, Si, Tianmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884949/
https://www.ncbi.nlm.nih.gov/pubmed/33603382
http://dx.doi.org/10.2147/NDT.S294521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884949/
https://www.ncbi.nlm.nih.gov/pubmed/33603382
http://dx.doi.org/10.2147/NDT.S294521

Ejemplares similares